Real-world quality of life (QoL) in patients with hormone receptor-positive (HR plus), human epidermal growth factor receptor 2-negative (HER2−), advanced breast cancer (ABC) treated with palbociclib: A patient-reported outcome (PRO) analysis from POLARIS - Karuturi, MS; Rocque, GB; Cappelleri, JC (Cancer Res, 2022)